Lion Point Capital’s Milestone Pharmaceuticals MIST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$976K	Buy	820,000 +65,000	+9%	+$114K	5.83%	4
2025 Q4	$1.53M	Buy	755,000 +96,447	+15%	+$208K	7.89%	1
2025 Q3	$1.32M	Buy	658,553 +109,747	+20%	+$193K	7.48%	2
2025 Q2	$1.06M	Hold	548,806	–	–	7.23%	7
2025 Q1	$439K	Sell	548,806 -477,000	-47%	-$948K	2.8%	15
2024 Q4	$2.42M	Sell	1,025,806 -628,348	-38%	-$1.08M	12.68%	2
2024 Q3	$2.51M	Sell	1,654,154 -686,053	-29%	-$998K	5.6%	5
2024 Q2	$3.09M	Buy	2,340,207 +40,000	+2%	+$64.3K	5.63%	5
2024 Q1	$4.12M	Buy	2,300,207 +650,000	+39%	+$1.06M	2.3%	6
2023 Q4	$2.76M	Buy	1,650,207 +1,200,000	+267%	+$3.26M	1.38%	6
2023 Q3	$1.4M	Hold	450,207	–	–	0.62%	13
2023 Q2	$1.28M	Buy	450,207 +25,000	+6%	+$94.3K	0.58%	13
2023 Q1	$1.68M	Hold	425,207	–	–	0.69%	18
2022 Q4	$2.89M	Sell	425,207 -1,132,026	-73%	-$5.96M	0.41%	22
2022 Q3	$11.2M	Buy	1,557,233 +608,663	+64%	+$4.62M	2.46%	13
2022 Q2	$5.63M	Buy	948,570 +265,000	+39%	+$1.63M	0.64%	24
2022 Q1	$4.39M	Buy	+683,570	New	+$4.27M	1.02%	22